Phosphorylation of p53 at threonine 155 is required for Jab1-mediated nuclear export of p53

BMB Reports

Volumn 50, Issue 7, 2017, Pages 373-378

  Lee, Eun Woo ^a   Oh, Wonkyung ^b   Song, Hosung Paul ^c   Kim, Won Kon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chosun University   (South Korea)

^c Korea International School   (South Korea)

Author keywords

COP9 signalosome; Curcumin; Hdm2; Jab1; P53

Indexed keywords

COP9 SIGNALOSOME; COPS5 PROTEIN, HUMAN; PEPTIDE HYDROLASE; PROTEIN P53; SIGNAL PEPTIDE; THREONINE;

CHEMISTRY; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL CULTURE;

COP9 SIGNALOSOME COMPLEX; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDE HYDROLASES; PHOSPHORYLATION; THREONINE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85026471330     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2017.50.7.077     Document Type: Article

References (35)

1. Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522
2. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16
3. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331
4. Vousden KH and Lu X (2002) Live or let die: the cell's response to p53. Nat Rev Cancer 2, 594-604
5. Haupt Y, Maya R, Kazaz A and Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299
6. Kubbutat MH, Jones SN and Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387, 299-303
7. Charni M, Aloni-Grinstein R, Molchadsky A and Rotter V (2017) p53 on the crossroad between regeneration and cancer. Cell Death Differ 24, 8-14
8. Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J 17, 554-564
9. Wei N and Deng XW (1999) Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet 15, 98-103
10. Tomoda K, Kubota Y, Arata Y et al (2002) The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 277, 2302-2310
11. Doronkin S, Djagaeva I and Beckendorf SK (2003) The COP9 signalosome promotes degradation of Cyclin E during early Drosophila oogenesis. Dev Cell 4, 699-710
12. Kim BC, Lee HJ, Park SH et al (2004) Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol Cell Biol 24, 2251-2262
13. Callige M, Kieffer I and Richard-Foy H (2005) CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor (alpha) by the proteasome. Mol Cell Biol 25, 4349-4358
14. Lee EW, Oh W and Song J (2006) Jab1 as a mediator of nuclear export and cytoplasmic degradation of p53. Mol Cells 22, 133-140
15. Oh W, Lee EW, Sung YH et al (2006) Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 281, 17457-17465
16. Oh W, Yang MR, Lee EW et al (2006) Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. J Biol Chem 281, 30166-30174
17. Kim JH, Choi JK, Cinghu S et al (2009) Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3. J Cell Biochem 107, 557-565
18. Guo H, Jing L, Cheng Y et al (2016) Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis. Hepatology 63, 898-913
19. Lu R, Hu X, Zhou J et al (2016) COPS5 amplification and overexpression confers tamoxifen-resistance in ERalphapositive breast cancer by degradation of NCoR. Nat Commun 7, 12044
20. Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S and Kato JY (2004) Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem 279, 43013-43018
21. Bech-Otschir D, Kraft R, Huang X et al (2001) COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J 20, 1630-1639
22. Yang WH, Kim JE, Nam HW et al (2006) Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8, 1074-1083
23. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ and Wahl GM (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18, 1660-1672
24. Carter S, Bischof O, Dejean A and Vousden KH (2007) C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 9, 428-435
25. Lohrum MA, Woods DB, Ludwig RL, Balint E and Vousden KH (2001) C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21, 8521-8532
26. Li M, Brooks CL, Wu-Baer F, Chen D, Baer R and Gu W (2003) Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302, 1972-1975
27. Coutts AS, Adams CJ and La Thangue NB (2009) p53 ubiquitination by Mdm2: a never ending tail? DNA Repair (Amst) 8, 483-490
28. Boyd SD, Tsai KY and Jacks T (2000) An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat Cell Biol 2, 563-568
29. Geyer RK, Yu ZK and Maki CG (2000) The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat Cell Biol 2, 569-573
30. Dai C and Gu W (2010) p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med 16, 528-536
31. Cai X and Liu X (2008) Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage. Proc Natl Acad Sci U S A 105, 16958-16963
32. Brooks CL and Gu W (2006) p53 ubiquitination: Mdm2 and beyond. Mol Cell 21, 307-315
33. Lee EW, Lee MS, Camus S et al (2009) Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis. EMBO J 28, 2100-2113
34. Seo J, Lee EW, Sung H et al (2016) CHIP controls necroptosis through ubiquitylation-and lysosomedependent degradation of RIPK3. Nat Cell Biol 18, 291-302
35. Lee EW, Kim JH, Ahn YH et al (2012) Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun 3, 978